Skip to content
Back to recalls
Drug FDA Class II Ongoing Failed specifications

Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11

Teva Pharmaceuticals USA, Inc Published Mar 11, 2026

Risk level

Class II

May cause a temporary or reversible health problem; slight chance of serious harm.

Severity score 60/100

What should you do?

  • Check whether you have this product, using the lot codes, UPCs, and dates listed below.
  • Do not eat, serve, or sell the affected product.
  • Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
  • Contact Teva Pharmaceuticals USA, Inc or your place of purchase with questions, and see the source record below for full details.
Reason for recall

Failed Dissolution Specifications

Hazards

Failed Dissolution · primary

Affected products (1)

Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11

METOPROLOL SUCCINATE · 19,056 bottles

NDC: 45963-676, 45963-709, 45963-677, 45963-678, 45963-709-11, 45963-709-96, 45963-676-11, 45963-676-96, 45963-677-11, 45963-677-96, 45963-678-11
Code info: Lot#: a) 0686H251, 0687H251, 10688H251, Exp.: 02/2027. .

Affected areas

Nationwide

Timeline

  1. Initiated
    Jan 29, 2026
  2. Published
    Mar 11, 2026
Recall number
D-0357-2026
Agency
U.S. Food and Drug Administration
Country
US
Source data (openFDA JSON) About FDA enforcement reports

FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.